Will Akili's therapeutic video game make any money?
Last week, the FDA deemed a video game an appropriate therapeutic to treat ADHD. Now, the game’s maker — Akili Interactive Labs — has to prove that this mode of treatment can actually make money, STAT’s Rebecca Robbins writes. Its performance could shape the field of digital therapeutics moving forward.
Some analysts are optimistic: The folks at Jefferies, for instance, project peak U.S. sales of $300 million. However, the game — called EndeavorRx — still hasn’t been given a price tag. The company said it’s not planning a one-time fee, but rather recurring payments for the treatment.
No hay comentarios:
Publicar un comentario